w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
[HTML][HTML] w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
P Zhang, Z Zheng, L Ling, X Yang, N Zhang, X Wang… - Autophagy, 2017 - ncbi.nlm.nih.gov
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway.
P Zhang, Z Zheng, L Ling, X Yang, N Zhang, X Wang… - Autophagy, 2017 - europepmc.org
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
P Zhang, Z Zheng, L Ling, X Yang, N Zhang… - …, 2017 - ingentaconnect.com
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
P Zhang, Z Zheng, L Ling, X Yang, N Zhang… - …, 2017 - pubmed.ncbi.nlm.nih.gov
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
[PDF][PDF] w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
P Zhang, Z Zheng, L Ling, X Yang, N Zhang… - …, 2017 - researchgate.net
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway.
P Zhang, Z Zheng, L Ling, X Yang, N Zhang, X Wang… - Autophagy, 2017 - europepmc.org
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
[PDF][PDF] w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway
P Zhang, Z Zheng, L Ling, X Yang, N Zhang… - …, 2017 - researchgate.net
The EGFR (epidermal growth factor receptor) signaling pathway is frequently deregulated in
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …
many malignancies. Therefore, targeting the EGFR pathway is regarded as a promising …